Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FATXF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,865
Award facts
- Contract value 100% obligated
- $10,864.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,864.73 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Eliquis 5 mg tablets in a 60-count package. The delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, carries no set-aside designation and represents a routine pharmaceutical procurement to support federal medical supply needs. The place of performance is Conshohocken, Pennsylvania.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy established to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor capable of delivering diverse pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables. The company's established performance on numerous prior delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FATXF?
SPE2DB26FATXF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FATXF worth?
The government has obligated $10,865 on SPE2DB26FATXF.
Is contract SPE2DB26FATXF an order under another contract?
Yes. SPE2DB26FATXF is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATXF competed?
The extent of competition for SPE2DB26FATXF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award